Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia

Abstract Negative symptoms are commonly assessed via clinical rating scales; however, these measures have several inherent limitations that impact validity and utility for their use in clinical trials. Objective digital phenotyping measures that overcome some of these limitations are now available....

Full description

Bibliographic Details
Main Authors: Gregory P. Strauss, Ian M. Raugh, Luyu Zhang, Lauren Luther, Hannah C. Chapman, Daniel N. Allen, Brian Kirkpatrick, Alex S. Cohen
Format: Article
Language:English
Published: Nature Portfolio 2022-04-01
Series:npj Schizophrenia
Online Access:https://doi.org/10.1038/s41537-022-00241-z